India
· Delayed Price · Currency is INR Cohance Lifesciences Company Description
Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India.
The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services.
It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals.
The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025.
The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
| Country | India |
| Founded | 1989 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,193 |
| CEO | Sudhir Singh |
Contact Details
Address: 202, B-Wing, Galaxy by Aurobindo Realty, Sy No 83/1 Hyderabad, 500081 India | |
| Phone | 91 40 4475 8595 |
| Website | cohance.com |
Stock Details
| Ticker Symbol | SUVENPHAR |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE03QK01018 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sudhir Kumar Singh Ph.D. | Chief Executive Officer |
| Vivek Sharma CPA | Executive Chairman |
| Himanshu Agarwal | Chief Financial Officer |
| Cyndrella Carvalho | Head of Investor Relations |
| Kundan Kumar Jha | Company Secretary and Compliance Officer |
| Gaurav Narain Bahadur | Chief Human Resources Officer |
| Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju Ph.D. | MD and Director |
| Dr. Declan Ryan Ph.D. | Chief Commercial Officer |
| Sunder Venkatraman | Vice President of Corporate Affairs |